The implantation process begins with attachment of the trophectoderm (TE) of the blastocyst to the maternal endometrial epithelium. Herein we have investigated the transcriptome of mural TE cells from 13 human blastocysts and compared these with those of human embryonic stem cell (hESC)-derived-TE (hESC troph ). The transcriptomes of hESC troph at Days 8, 10, and 12 had the greatest consistency with TE. Among genes coding for secreted proteins of the TE of human blastocysts and of hESC troph are several molecules known to be involved in the implantation process, as well as novel ones, such as CXCL12, HBEGF, inhibin A, DKK3, WNT5A, and follistatin. The similarities between the two lineages underscore some of the known mechanisms and offer discovery of new mechanisms and players in the process of the very early stages of human implantation. We propose that the hESC troph is a viable functional model of human trophoblasts to study trophoblast-endometrial interactions. Furthermore, the data derived herein offer the promise of novel diagnostics and therapeutics aimed at practical challenges in human infertility and pregnancy disorders associated with abnormal embryonic implantation.
INTRODUCTION
Embryonic implantation is a complex process that occurs in a specific spatio-temporal program. It requires a functionally normal blastocyst and occurs only when the endometrium is receptive-during the ''window of implantation,'' 6-10 days after the luteinizing hormone surge [1, 2] . Receptivity is a consequence of an orderly response of endometrial cellular components to circulating estradiol and progesterone during the menstrual cycle, with reciprocal embryo-endometrial interactions likely enhancing this process [1, [3] [4] [5] [6] . The embryo is guided by largely unknown factors to a specific region of the maternal endometrium, and the implantation process begins with attachment of the blastocyst trophectoderm (TE) to the endometrial luminal epithelium [1, 5, 6] . Subsequently, the conceptus intrudes through the epithelium, traversing its basement membrane, followed by the differentiated trophoblast invading into the stromal compartment-a process that involves dynamic cross talk between trophoblasts, endometrial cells, and the extracellular matrix [3, 4] . The end result is anchoring the conceptus, establishing a vascular supply for optimal growth and development, and protecting the fetal allograft from rejection by the maternal immune system. Abnormalities in any of these processes can result in infertility, miscarriage, intrauterine fetal growth restriction, and preeclampsia [1, 3, 4] .
The TE is the trophoblast phenotype comprising the outer ''cellular shell'' of the blastocyst that participates in the early events of implantation, whereas later events are associated with trophoblast acquisition of the invasive and vascular phenotypes [3, 4] .
Trophectoderm is subdivided into polar and mural components. The former overlies the inner cell mass and is involved in the initial contact with the endometrium, whereas the latter is involved in subsequent interactions with endometrium as implantation proceeds. Cells move from the polar to mural regions in mouse blastocysts as they develop [7, 8] , and genetic differences/similarities between these two TE cell types are unknown currently. Furthermore, there is scant information about molecules involved in blastocyst attachment to the endometrium in humans, primarily because of lack of available tissues (human blastocysts) for study and federal restrictions on experimentation with human embryos. In addition, trophoblasts isolated from terminations of pregnancy (either early or late) are already differentiated beyond the TE stage. The majority of information derives from rare reports with human embryos [6] and/or gene expression studies of the maternal endometrium in the implantation window in nonpregnant cycles [9] [10] [11] , with an inference of ligands or receptors on the TE.
Assisted reproduction implantation rates and pregnancy rates continue to hover around 20% and 34%, respectively, nationwide [12] . This low implantation rate has given rise to increased numbers of embryos transferred [13] with consequent risks of multiple gestation, as well as debate about how to choose the best embryo for transfer and commercial efforts to develop adjunctive factors to increase endometrial receptivity to embryo implantation [14, 15] . Understanding mechanisms underlying the processes involved in human implantation is critical to improve in vitro fertilization (IVF) success rates, as well as to develop diagnostics for embryo quality and therapies for endometrium-based implantation disorders.
We have previously reported on differentiating human embryonic stem cells (hESC; H7 and H9 NIH lines) into trophoblast-like cells that produce bhCG and express TEspecific markers [16] . Herein, we have investigated the transcriptome of mural TE from human blastocysts and compared it to hESC differentiated to the trophoblast lineage (hESC troph ) [16] . The data underscore numerous participants in the early phase of human implantation and support the fidelity of hESC troph as a model of human TE.
MATERIALS AND METHODS

Human Embryos
Fifty-eight Day-3 cryopreserved human embryos were obtained from nine subjects through the University of California, San Francisco (UCSF), IVF Tissue Bank after approval from the UCSF Committee on Human Research and the UCSF Gamete, Embryo, and Stem Cell Research Oversight Committee. Embryos were thawed and cultured in G2 version 5 medium (Vitrolife, Denver, CO) supplemented with 10% synthetic serum substitute (Irvine Scientific, Irvine, CA) in 5% O 2 and 6% CO 2 incubator until the blastocyst stage (Days 5-6). Sixteen surviving blastocysts were subjected to mural TE biopsy (the polar TE was technically impossible to separate from the inner cell mass), and TE cells were successfully isolated from 13 blastocysts. Each blastocyst was placed in a 20-ll droplet of biopsy medium (Cooper Surgical, Pasadena, CA) with 5% human serum albumin (Cooper Surgical) and covered with mineral oil (Irvine Scientific). Embryos were rotated so that the inner cell mass was positioned at 9 o'clock, after which a holding pipette gently held the blastocyst, and the zona pellucida was opened at a focal area at the 3 o'clock position using a laser (Zilos; Hamilton Thorne, Beverly, MA). A biopsy pipette (Humagen, Origio, Denmark) with an inner diameter of 30 lm was used to aspirate the TE cells. The laser was used to separate the biopsied cells from the remaining embryo. Care was taken to avoid aspirating cells from the inner cell mass while maximizing the yield of the TE cells. After the biopsy, the TE cells and the remaining embryos were placed into different tubes for molecular analysis. The age ranges of the female and male donors of the embryos were 29-42 yr old (mean 37 6 1.51) and 33-56 yr old (mean 40.9 6 2.55), respectively. Diagnoses for undergoing fertility treatment were endometriosis and premature ovarian failure, and IVF treatment was performed for a family history of cystic fibrosis.
Total RNA Isolation, Amplification, and Microarray Hybridization
As the total number of cells obtained per thawed embryo varied between 3 and 12, TE cells from two or three blastocysts were pooled. Five pools (two 2-subject pools and three 3-subject pools) were subjected to RNA isolation and purification with DNAse treatment using PicoPure RNA Isolation Kit (Molecular Devices, Sunnyvale, CA), which recovers high-quality RNA from low-cell-number samples. RNA was amplified and converted to cDNA using the WT-Ovation FFPE System (NuGEN Technolgies Inc., San Carlos, CA), and cDNA was generated using WT-Ovation Exon Module (NuGEN Technologies Inc.). After amplification and cDNA synthesis, one sample was excluded due to low cDNA yield. Yields of the cDNA of the four remaining samples ranged from 3276-8036 ng (mean 5404 6 1029.8 ng) and were of sufficient quality to submit for hybridization on Affymetrix Gene 1.0 ST arrays (Affymetrix, Inc., Santa Clara, CA) as described [17, 18] .
Microarray Gene Expression Data Analysis
The resulting data were compared to the transcriptomes of hESC differentiated to the trophoblast lineage (hESC troph ) after 0, 2, 4, 6, 8, 10, and 12 days of induction with BMP-4 (data from [16] ) using GeneSpring GX 10.0 and then analyzed with Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA) software [17] [18] [19] . Raw data files of the experiments have been uploaded to the National Center for Biotechnology Information Gene Expression Omnibus GEO database with the identifier GSE30650. Hierarchical clustering, an unsupervised way to group samples based only on their gene expression similarities, and Principal Component Analysis (PCA), an unsupervised pattern recognition and visualization tool used to analyze large amounts of data derived from array gene expression and based on similarities in gene expression patterns in our experimental groups, were conducted as described [11, 18] . Validation of selected genes in TE was performed using quantitative (Q) real-time RT-PCR (see below).
Microarray Validation by Real-Time PCR
For Q-RT-PCR analysis, 0.5 lg of RNA was converted to cDNA using the iScript cDNA Synthesis kit (Bio-Rad Laboratories, Hercules, CA). The Q-RT-PCR reaction was carried out for 40 cycles with the primers listed in Table 1 . Q-RT-PCR was performed in duplicate according to the manufacturer's instructions and as described earlier [18, 20] .
RESULTS
Microarray Data Analysis
Comparison of the transcriptomes of TE with hESC troph at Days 0, 2, 4, 6, 8, 10, and 12 [16] revealed 138 genes in common, with 121 of these being eligible to generate networks and canonical pathways. The differentially expressed genes of TE as compared to undifferentiated hESC (at Day 0 of induction) were most consistent with the gene signatures of the hESC troph at later stages of in vitro differentiation (Days 8, 10, and 12), with 563 differentially expressed genes in common vs. the Day 0 undifferentiated hESC (Table 2 ). In contrast, the earlier stages of hESC troph in vitro differentiation (Days 2, 4, and 6) had only 167 differentially expressed genes in common with the TE. Interestingly, TE clustered separately from all hESC troph on PCA, which may reflect differences between cultured and freshly isolated cells, or, alternatively, differences between the cell types in the study (Fig. 1A) . Hierarchical clustering (Fig.  1B) demonstrated that early differentiated hESC troph (Days 2-4) clustered together, while hESC troph at later differentiation stages (Days 6-12) clustered together, with TE standing separately from hESC as a group.
Pregnancy-specific beta-1-glycoproteins (PSG), which interact with integrin receptors and are abundantly expressed in the fetal trophoblast and secreted into the maternal circulation, were among 138 genes in common between TE with hESC troph . The genes involved in calcium signaling (RCAN2, ITPR3), G protein-coupled receptor signaling (PLCB4, RGS2, and RGS4), and Notch signaling were also in common between TE and hESC troph . Leukemia inhibitory factor (LIF) and its specific receptor LIFR are among common genes in the two comparisons.
The major canonical pathways ( (Table 4) included: cell death, cellto-cell signaling and interaction; cell cycle, cellular assembly and organization, DNA replication, recombination, and repair; genetic disorder, hepatic system disease, tissue development; developmental disorder, neurological disease, cellular assem- bly and organization; inflammatory response, cardiovascular system development and function; and organismal development. The scores and number of molecules involved are presented in Table 4 .
hESC-DERIVED-TE AS A MODEL OF HUMAN TROPHOBLAST
Periostin, osteoblast specific factor Extracellular space Other PPAP2B Phosphatidic acid phosphatase type 2B Plasma membrane Phosphatase PPP1R3C Protein phosphatase 1, regulatory (inhibitor) subunit 3C Cytoplasm Phosphatase PRC1 Protein regulator of cytokinesis 1 Nucleus Other PRELP Proline/arginine-rich end leucine-rich repeat protein Extracellular space Other PRKCA Protein kinase C, alpha Cytoplasm Kinase PRKD1 Protein kinase D1 Cytoplasm Kinase PROS1 Protein S (alpha) Extracellular space Other PRR11 Proline rich 11 Unknown Other PRUNE2 Prune homolog 2 (Drosophila) Unknown Other PSAT1 Phosphoserine aminotransferase 1 Cytoplasm Enzyme PSD3 Pleckstrin and Sec7 domain containing 3 Unknown Other PSG4 Pregnancy specific beta-1-glycoprotein 4 Extracellular space Other PTGIS Prostaglandin I2 (prostacyclin) synthase Cytoplasm Enzyme PTGR1 Prostaglandin reductase 1 Cytoplasm Enzyme PTTG1 Pituitary tumor-transforming 1 Nucleus Transcription regulator PTX3 Pentraxin-related gene, rapidly induced by IL-1 beta Extracellular space Other PYGL Phosphorylase, glycogen, liver Unknown Enzyme QPCT (includes EG:25797) Glutaminyl-peptide cyclotransferase Extracellular space Enzyme RAB23 RAB23, member RAS oncogene family Cytoplasm Enzyme RAB27B RAB27B, member RAS oncogene family Cytoplasm Enzyme RAB3B RAB3B, member RAS oncogene family Cytoplasm Enzyme RACGAP1 Rac GTPase
Validation
Real-time RT-PCR validated trophoblast-specific genes [21]
HLA-G, CDX2, and ID2 in TE cells isolated from human blastocysts (Fig. 2) . We were not able to perform further validation because there was a low number of cells and therefore not a sufficient amount of RNA left after the microarray analysis.
Genes Coding for Human Trophectoderm Secreted Proteins
From the list of genes common to TE and hESC troph , we derived the projected complement of secreted proteins (Table  5) . Interestingly, among those of the TE of human blastocysts and hESC are LIF, some cytokines, growth factors, extracellular matrix proteins, inhibin, follistatin, and members of the WNT and Notch families, widely reported previously to be involved in the implantation process [22, 23] .
DISCUSSION
The current study is unique in its comparison of the transcriptome of human TE with that of hESC troph , and we propose the utility of this experimental model to study human endometrial-embryonic interactions. We found in the present study that hESC troph at Days 8, 10, and 12 is most similar to TE and is thus suitable as a model of human trophoblasts for subsequent studies of trophoblast-endometrial interactions.
Transcriptome of the Early Human Embryo
Of the two main participants in the implantation process, the endometrium and the embryo, the genome-wide changes in endometrium during the menstrual cycle and the implantation window in particular have been widely investigated [10, 11, [24] [25] [26] [27] [28] , whereas data are limited regarding gene expression profiles in the human pre-implantation embryo. Dobson et al. [29] conducted microarray analysis of human preimplantation embryos during the first 3 days of embryonic development (up to the 8-cell stage). Adjaye et al. [30] studied blastocyst-stage human embryos, with the main focus on differential gene expression between the cells of inner cell mass (ICM) and TE using a cDNA microarray (Ensembl Chip) consisting of 15 529 resequenced and annotated clones. They identified 2880 genes as specific for the blastocyst, where 2031 genes were in common between the intact blastocyst, ICM, and TE. Few genes were specifically expressed in either ICM (292) or TE (345). Pathway analysis identified several signaling pathways that were activated in TE compared to ICM, such as MAPK, starch and sucrose metabolism, WNT, integrin, Toll-like receptor, cell cycle, TGF-beta, inositol phosphate metabolism, Notch, and other signaling pathways, many of which are similar to the findings in the present study (Table 3 ). The Remarkably, the majority of these pathways have been reported to be highly involved in the development of receptive endometrium during implantation process (see review [24] ), which strongly supports involvement of these pathways and players in the cross-communication between blastocyst and endometrium during nidation.
Genes Coding for TE-Secreted Proteins
Among the key secreted proteins coded by the TE transcriptome is LIF, which is also expressed by the hESC [31] . LIF has been measured in uterine secretions and uterine flushings in attempts to assess endometrial function and implantation potential [24, 32] and is expressed by both embryo and endometrium. Also among secreted protein candidates are the mature soluble form of HBEGF, a potent stimulator of cell proliferation, migration, and motility [33] , and adrenomedullin and other growth factors and cytokines. hESC-DERIVED-TE AS A MODEL OF HUMAN TROPHOBLAST hESC-DERIVED-TE AS A MODEL OF HUMAN TROPHOBLAST We also identified secreted biomarkers in TE and hESC troph , which, though needing further validation, have great promise in developing diagnostic tests to assess embryo quality in human IVF and targeted therapies to enhance endometrial receptivity to embryonic implantation in women with implantation-based infertility and/or implantation-based pregnancy disorders and poor pregnancy outcomes. It is noteworthy that the TE secretome is comprised of molecular partners and ligands of established biomarkers of endometrial receptivity and/or their receptors, underscoring reciprocity between endometrial surface and TE cells of the implanting blastocyst.
A Different Model for TE Studies
After completion of the current study, Genbacev et al. [34] reported derivation of hESC from single blastomeres of 8-cell human embryos, i.e., before ICM and TE differentiation. These cells spontaneously differentiate into trophoblast cells, confirmed by expression of TE markers [34] . Moreover, since some blastomeres from the same embryo have a higher rate of spontaneous differentiation into trophoblast-like cells [34] , comparative studies with the single-blastomere-derived hESC troph and human TE are important to understand further the molecular basis of cell fate decisions and to develop models of human TE.
Herein, we have presented a comparison of the transcriptomes and candidate secreted proteins of human TE and hESC-derived trophoblast-like cells differentiated in vitro for 8, 10, and 12 days. There are many similarities between the two lineages, which underscore some of the known mechanisms and offer discovery of new mechanisms and players in the process of the very early stages of human implantation. We suggest that the hESC troph is a viable model of human trophoblasts for studies of trophoblast-endometrial interactions. Furthermore, the data derived herein, while needing further validation, offer the promise of novel diagnostics and therapeutics aimed at practical challenges in human infertility and pregnancy disorders associated with abnormal embryonic implantation. Pregnancy specific beta-1-glycoprotein 7 j pregnancy specific beta-1-glycoprotein 4 PTX3
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